Graybug Vision Stock

graybug.comHealthcareFounded: 2011Funding to Date: $160.77MM

Graybug Vision is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of chronic diseases of the retina and optic nerve.

Register for Details

For more details on financing and valuation for Graybug Vision, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Graybug Vision.

Register Today

Team

Management Team

Dan Salain
Chief Operating Officer
Charles Semba MD
Chief Medical Officer
Frédéric Guerard
Chief Executive Officer & Board Member
Peter Campochiaro MD
Co-Founder
Justin Hanes Ph.D
Co-Founder & Board Member
Pamela Wapnick
Chief Financial Officer
Peter McDonnell MD
Co-Founder

Board Members

Chau Khuong
OrbiMed
Hansoo Keyoung
Cameron Wheeler Ph.D
Deerfield Management
Gerald Cagle Ph.D
Christy Shaffer Ph.D
Emmett Cunningham Ph.D
Clarus Ventures
Frédéric Guerard
Justin Hanes Ph.D

Other companies like Graybug Vision in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

Graybug Vision, Inc., a clinical stage pharmaceutical company developing potentially transformative long-acting therapies for ocular diseases includin